Fabienne Rajas

A hypometabolic defense strategy against malaria

mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease

Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy

Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease

Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a

The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice

Glucose-6 Phosphate, a Central Hub for Liver Carbohydrate Metabolism

Glucose‐6‐Phosphate Regulates Hepatic Bile Acid Synthesis in Mice

Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context

G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a

Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia

Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases

Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia

Metabolic Adaptation Establishes Disease Tolerance to Sepsis

Gut-Brain Glucose Signaling in Energy Homeostasis

Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD

Review of the nutritional benefits and risks related to intense sweeteners

A link between hepatic glucose production and peripheral energy metabolism via hepatokines

Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy

A liver Hif-2α–Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition

Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders

Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice

Mu-Opioid Receptors and Dietary Protein Stimulate a Gut-Brain Neural Circuitry Limiting Food Intake

Glucotoxicity Induces Glucose-6-Phosphatase Catalytic Unit Expression by Acting on the Interaction of HIF-1α With CREB-Binding Protein